Literature DB >> 31932132

Evaluation of opioid requirements in the management of renal colic after guideline implementation in the emergency department.

Faisal Syed Minhaj1, Mercy Hoang-Nguyen2, Austin Tenney3, Andrew Bragg3, Wen Zhang3, Justin Foster2, Jason Rotoli3, Nicole M Acquisto4.   

Abstract

PURPOSE: Evaluate opioid prescribing before and after emergency department (ED) renal colic guideline implementation focused on multi-modal pain management.
METHODS: Retrospective study of ED patients who received analgesia for urolithiasis before and after guideline implementation. The guideline recommends oral acetaminophen, intravenous (IV) ketorolac, and a fluid bolus as first line, IV lidocaine as second line, and opioids as refractory therapy to control pain. Opioid exposure, adverse effects, length of stay (LOS), and ED representation were evaluated. Comparisons were made with univariate analyses. Backwards stepwise binomial multivariate logistic regression to identify factors related to opioid use was performed.
RESULTS: Overall, 962 patients were included (451 pre- and 511 post-implementation). ED and discharge opioid use decreased; 65% vs. 58% and 71% vs. 63% in pre- and post-implementation groups, respectively. More post-implementation patients received non-opioid analgesia (65% vs. 56%) and non-opioid analgesia prior to opioids (50% vs. 38%). A longer ED LOS and higher initial pain score were associated with ED opioid administration. Guideline implementation, receiving non-opioid therapy first, and first renal colic episode were associated with decreased ED opioid administration. Seventeen adverse events (1.8%) were reported. There was no difference in change in ED pain score between groups, but patients in the post-implementation group were admitted more and had a higher 7-day ED representation (11% vs. 7%).
CONCLUSIONS: A multimodal analgesia protocol for renal colic was associated with decreased opioid prescribing, higher rates of admission to the hospital, and a higher 7-day ED representation rate.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Emergency department; Lidocaine; Nephrolithiasis; Opioid; Pain; Renal colic; Urolithiasis

Year:  2019        PMID: 31932132     DOI: 10.1016/j.ajem.2019.12.042

Source DB:  PubMed          Journal:  Am J Emerg Med        ISSN: 0735-6757            Impact factor:   2.469


  5 in total

1.  Canadian Urological Association guideline: Management of ureteral calculi - Abridged version.

Authors:  Jason Y Lee; Sero Andonian; Naeem Bhojani; Jennifer Bjazevic; Ben H Chew; Shubha De; Hazem Elmansy; Andrea G Lantz-Powers; Kenneth T Pace; Trevor D Schuler; Rajiv K Singal; Peter Wang; Michael Ordon
Journal:  Can Urol Assoc J       Date:  2021-12       Impact factor: 1.862

2.  Canadian Urological Association guideline: Management of ureteral calculi - Full-text.

Authors:  Jason Y Lee; Sero Andonian; Naeem Bhojani; Jennifer Bjazevic; Ben H Chew; Shubha De; Hazem Elmansy; Andrea G Lantz-Powers; Kenneth T Pace; Trevor D Schuler; Rajiv K Singal; Peter Wang; Michael Ordon
Journal:  Can Urol Assoc J       Date:  2021-12       Impact factor: 1.862

3.  Opioid Analgesics and Persistent Pain After an Acute Pain Emergency Department Visit: Evidence from a Cohort of Suspected Urolithiasis Patients.

Authors:  Anna E Wentz; Ralph C Wang; Brandon D L Marshall; Theresa I Shireman; Tao Liu; Roland C Merchant
Journal:  J Emerg Med       Date:  2021-10-21       Impact factor: 1.473

4.  Evaluation of Interventions to Reduce Opioid Prescribing for Patients Discharged From the Emergency Department: A Systematic Review and Meta-analysis.

Authors:  Raoul Daoust; Jean Paquet; Martin Marquis; Jean-Marc Chauny; David Williamson; Vérilibe Huard; Caroline Arbour; Marcel Émond; Alexis Cournoyer
Journal:  JAMA Netw Open       Date:  2022-01-04

5.  Analgesic and Opioid Use for Patients Discharged from the Emergency Department with Ureteral Stones.

Authors:  Andrew C Meltzer; Allan B Wolfson; Patrick Mufarrij; Cora MacPherson; Nataly Montano; Ziya Kirkali; Pamela Katzen Burrows; Stephen V Jackman
Journal:  J Endourol       Date:  2021-01-21       Impact factor: 2.619

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.